documents: FDA-2019-N-1132-0116

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2019-N-1132-0116 FDA FDA-2019-N-1132 Transcript - The Future of Insulin Biosimilars increasing access and facilitating the efficient development of biosimilar and interchangeable insulin products Other Transcript(s) 2019-05-29T04:00:00Z 2019 5 2019-05-29T04:00:00Z   2019-05-29T13:18:29Z   0 0 0900006483cd08ce

Links from other tables